Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
Journal of Viral Hepatitis
|
September 8, 2021
Derivation and validation of prognostic models for predicting survival outcomes in Acute-on-chronic liver failure patients
Fajuan Rui, Hongli Yang, Zhaoyang Guo, et al.
European Journal of Radiology
|
May 13, 2023
Microwave ablation versus radiofrequency ablation as bridge therapy in potentially transplantable patients with single HCC ≤ 3 cm: A propensity score-matched study
Xueqi Wang, Hongli Yu, Fenglin Zhao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 6, 2025
Inhibition of ASIC1a reduces ferroptosis in rheumatoid arthritis articular chondrocytes via the p53/NRF2/SLC7A11 pathway
Jie Tang, Wenqiang Liu, Zihan Li, et al.
Theranostics
|
September 18, 2025
RIPK3 promotes ASIC1a-mediated fibroblast-like synoviocyte migration and invasion via malate shuttle-driven mitochondrial respiration in rheumatoid arthritis
Weirong Hu, Ke Wang, Yalu Dong, et al.
Alimentary Pharmacology & Therapeutics
|
June 23, 2022
Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021
Jie Li, Audrey Ha, Fajuan Rui, et al.
The Journal of Infectious Diseases
|
May 29, 2026
Switching to Daily Doravirine/Islatravir (100/0.25 mg) Maintains Viral Suppression Through Week 48 Despite Baseline Non-Nucleoside Reverse Transcriptase Inhibitor Resistance-Associated Mutations or M184I/V in Proviral DNA
Tracy L Diamond, Anjana Grandhi, Monica Fuszard, et al.
The British Journal of Dermatology
|
November 24, 2025
Safety and efficacy of stapokibart, an anti-IL-4Rα monoclonal antibody, in children aged 6-11 years with moderate-to-severe atopic dermatitis: An open-label, single-arm phase 1b/2a trial
Mutong Zhao, Zigang Xu, Liming Wu, et al.
Research Square
|
July 3, 2023
Obesity-dependent increase in RalA activity disrupts mitochondrial dynamics in white adipocytes
Wenmin Xia, Preethi Veeragandham, Yu Cao, et al.
The Lancet. HIV
|
February 28, 2026
Fixed-dose daily doravirine (100 mg) with islatravir (0·25 mg) versus bictegravir, emtricitabine, and tenofovir alafenamide for initial HIV-1 therapy: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial
Jürgen K Rockstroh, Sheetal Kassim, Roger Paredes, et al.
The Journal of Infection
|
September 10, 2023
Molnupiravir for intra-household prevention of COVID-19: The MOVe-AHEAD randomized, placebo-controlled trial
Sady A Alpizar, Jose Accini, Duane C Anderson, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
Journal of Viral Hepatitis
|
September 8, 2021
Derivation and validation of prognostic models for predicting survival outcomes in Acute-on-chronic liver failure patients
Fajuan Rui, Hongli Yang, Zhaoyang Guo, et al.
European Journal of Radiology
|
May 13, 2023
Microwave ablation versus radiofrequency ablation as bridge therapy in potentially transplantable patients with single HCC ≤ 3 cm: A propensity score-matched study
Xueqi Wang, Hongli Yu, Fenglin Zhao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 6, 2025
Inhibition of ASIC1a reduces ferroptosis in rheumatoid arthritis articular chondrocytes via the p53/NRF2/SLC7A11 pathway
Jie Tang, Wenqiang Liu, Zihan Li, et al.
Theranostics
|
September 18, 2025
RIPK3 promotes ASIC1a-mediated fibroblast-like synoviocyte migration and invasion via malate shuttle-driven mitochondrial respiration in rheumatoid arthritis
Weirong Hu, Ke Wang, Yalu Dong, et al.
Alimentary Pharmacology & Therapeutics
|
June 23, 2022
Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021
Jie Li, Audrey Ha, Fajuan Rui, et al.
The Journal of Infectious Diseases
|
May 29, 2026
Switching to Daily Doravirine/Islatravir (100/0.25 mg) Maintains Viral Suppression Through Week 48 Despite Baseline Non-Nucleoside Reverse Transcriptase Inhibitor Resistance-Associated Mutations or M184I/V in Proviral DNA
Tracy L Diamond, Anjana Grandhi, Monica Fuszard, et al.
The British Journal of Dermatology
|
November 24, 2025
Safety and efficacy of stapokibart, an anti-IL-4Rα monoclonal antibody, in children aged 6-11 years with moderate-to-severe atopic dermatitis: An open-label, single-arm phase 1b/2a trial
Mutong Zhao, Zigang Xu, Liming Wu, et al.
Research Square
|
July 3, 2023
Obesity-dependent increase in RalA activity disrupts mitochondrial dynamics in white adipocytes
Wenmin Xia, Preethi Veeragandham, Yu Cao, et al.
The Lancet. HIV
|
February 28, 2026
Fixed-dose daily doravirine (100 mg) with islatravir (0·25 mg) versus bictegravir, emtricitabine, and tenofovir alafenamide for initial HIV-1 therapy: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial
Jürgen K Rockstroh, Sheetal Kassim, Roger Paredes, et al.
The Journal of Infection
|
September 10, 2023
Molnupiravir for intra-household prevention of COVID-19: The MOVe-AHEAD randomized, placebo-controlled trial
Sady A Alpizar, Jose Accini, Duane C Anderson, et al.
Page
of 9